Phase I/II Trial of Radiosurgery Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Irinotecan
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
Most Recent Events
- 03 Jul 2018 Biomarkers information updated
- 10 Oct 2013 Planned end date changed from 1 Dec 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
- 29 Sep 2010 New trial record